Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

about

Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy.Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction.

P2860

Q48344587-8F2CA64F-936A-48A4-BC56-A037A7BBB305 Q54981195-B48452CD-AEA3-46FA-98E8-8B3398177509

P2860

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

Item

http://www.wikidata.org/entity/Q48628910

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Rationale and Design of the Ef ...... arction (ELECTRA) pilot study.

@en

Rationale and Design of the Ef ...... ly After myocardial infarction

@nl

type

Item

label

Rationale and Design of the Ef ...... arction (ELECTRA) pilot study.

@en

Rationale and Design of the Ef ...... ly After myocardial infarction

@nl

prefLabel

Rationale and Design of the Ef ...... arction (ELECTRA) pilot study.

@en

Rationale and Design of the Ef ...... ly After myocardial infarction

@nl

P1476

Rationale and Design of the Ef ...... arction (ELECTRA) pilot study.

@en

P2093

Aldona Kubica

http://www.w3.org/2001/XMLSchema#string

Bernd Jilma

http://www.w3.org/2001/XMLSchema#string

Dimitrios Alexopoulos

http://www.w3.org/2001/XMLSchema#string

Eliano P Navarese

http://www.w3.org/2001/XMLSchema#string

Katarzyna Buszko

http://www.w3.org/2001/XMLSchema#string

Przemyslaw Paciorek

http://www.w3.org/2001/XMLSchema#string

Tomasz Fabiszak

http://www.w3.org/2001/XMLSchema#string

Wiktor Kuliczkowski

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

Dual antiplatelet therapy: optimal timing, management, and duration

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Third universal definition of myocardial infarction.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.

P31

scholarly article

P356

10.1093/EHJCVP/PVX032

http://www.w3.org/2001/XMLSchema#string

P50

Jacek Kubica

Piotr Adamski

P577

2017-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29040445

http://www.w3.org/2001/XMLSchema#string

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

about

P2860

P2860

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698